ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
If you’ve spent time online recently, you’ve probably heard of insulin resistance. People using injectable drugs such as Ozempic talk about it. Fitness enthusiasts suggest exercise routines to reverse ...
ORLANDO, Fla. — The inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin treatment option for people with type 1 diabetes, new phase 4 data suggest. Afrezza ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback